CN101301461A - Medicament for treating urticaria - Google Patents
Medicament for treating urticaria Download PDFInfo
- Publication number
- CN101301461A CN101301461A CNA2008100553023A CN200810055302A CN101301461A CN 101301461 A CN101301461 A CN 101301461A CN A2008100553023 A CNA2008100553023 A CN A2008100553023A CN 200810055302 A CN200810055302 A CN 200810055302A CN 101301461 A CN101301461 A CN 101301461A
- Authority
- CN
- China
- Prior art keywords
- medicine
- urticaria
- regulating
- treatment
- thick paste
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A medicine for curing urticaria adopts raw materials of ginger, mulberry bark, purple common perilla and kudzuvine root. The raw materials are decocted with water to obtain decoction liquid which is condensed into thick paste with a relative density of 1.25 to 1.3. The thick paste is dried, crushed and then encapsulated to make a capsule. The medicine has the functions of clearing away dampness and relieving itching, dispelling wind and coldness, removing heat from the blood and regulating the stomach, detoxifying and relaxing the bowels, regulating ying and wei, benefiting qi and enriching the blood, and regulating the immunity of a human body. The medicine can quickly relieve itching of an urticaria patient, and subside a wheal without relapse and with higher curative action on urticaria. The medicine has a remarkable effect on curing various insomnias due to acute and chronic urticaria with a curative ratio of above 96 percent without any toxic and side effect.
Description
Technical field
The present invention relates to the urticarial medicine of a kind of treatment, especially relating to a kind of is the urticarial medicine of treatment of feedstock production with the Chinese crude drug, the invention still further relates to the preparation method of this medicine.
Background technology
Urticaria belongs to the anaphylactic disease category, and its cardinal symptom is a pruritus, and clinical manifestation is the localized edema welt that differs in size.The welt color can be cerise, pale red, pale asphyxia or skin-color, and form can rounded, oval, annular or irregular shape.Welt can take place suddenly in several minutes, can disappear in several minutes to a few hours, did not stay any vestige, but this plays that again, outbreak repeatedly.According to course of disease length, generally that onset is anxious, the course of disease was called acute urticaria at three months with interior person, and its morbidity is hurried, the welt number is more, how with General Symptoms.Welt shows effect repeatedly and is called chronic urticaria above person more than three months, and is few for a long time during its welt, but most welt is less, and General Symptoms is lighter.
The treatment urticaria generally adopts Claritin at present, as hismanal, clarityne, quick enlightening, tranilast, mizolastine etc., though these medicines can play certain therapeutical effect to urticaria, but easily produce the drowsiness side effect of Denging, and dependency is big, and cure rate is low, can not thoroughly effect a radical cure.
Summary of the invention
The objective of the invention is to overcome the deficiency of conventional medicament, a kind of determined curative effect is provided, the urticarial medicine of treatment that side effect is little.
Medicine of the present invention is that the Chinese medicine by following ratio of weight and number is that crude drug prepares:
Rhizoma Zingiberis Recens 10～20 Cortex Mori 15～25
Folium Perillae 10～20 Radix Puerariaes 15～25.
The preferred weight portion rate of described each component is:
Rhizoma Zingiberis Recens 10～15 Cortex Mori 15～20
Folium Perillae 10～15 Radix Puerariaes 15～20.
The medicine of above-mentioned each component can be made said dosage form on any pharmaceuticss such as tablet, pill, granule, capsule, and the preferred dosage form of the present invention is a capsule.
The concrete preparation method of above-mentioned each component being made medicine of the present invention is:
With above-mentioned various medicines according to described parts by weight mix homogeneously, decoct with water 3 times, each 0.5～1 hour, merge 3 times decocting liquid, being condensed into relative density after the filtration is the thick paste of 1.25～1.3 (60 ℃), after 50～60 ℃ of dryings, be ground into 100～120 purpose medicated powder, sterilization makes the capsule product in incapsulating.
Clearly wet antipruritic, the expelling wind and cold of medicine of the present invention, removing heat from blood stomach function regulating, detoxifcation relieving constipation, harmonizing yingfen and weifen, benefiting QI and nourishing blood, has the effect of adjusting the human immunologic function, the urticaria patient that can make very itches feels bad is antipruritic fast, welt disappears, do not recur, urticaria there is higher curative effect, and can toxigenicity and side effect to human body.
Use Drug therapy urticaria of the present invention clinically, wherein 100 examples are observed in the acute urticaria treatment, take medicine 1 dose, cure 98 examples, and cure rate is 98%.500 examples are observed in the chronic urticaria treatment, take medicine 3 doses and cure 480 examples, cure rate 96%.
The specific embodiment
Embodiment 1
Get Rhizoma Zingiberis Recens 200g, Cortex Mori 300g, Folium Perillae 200g, Radix Puerariae 300g mix homogeneously, decoct with water 3 times, each water 3Kg decocted 0.5 hour, 3 decocting liquids are merged, filter, being condensed into relative density is the thick paste of 1.25 (60 ℃), after 60 ℃ of dryings, be ground into 120 purpose medicated powder, in incapsulating, sterilization makes the capsule product.
Embodiment 2
Get Rhizoma Zingiberis Recens 300g, Cortex Mori 400g, Folium Perillae 300g, Radix Puerariae 400g mix homogeneously, decoct with water 3 times, each water 5Kg decocted 1 hour, 3 decocting liquids are merged, filter, being condensed into relative density is the thick paste of 1.25 (60 ℃), after 60 ℃ of dryings, be ground into 100 purpose medicated powder, in incapsulating, sterilization makes the capsule product.
Claims (4)
1, the urticarial medicine of a kind of treatment is that the Chinese medicine by the following portions by weight ratio is that crude drug prepares:
Rhizoma Zingiberis Recens 10～20 Cortex Mori 15～25
Folium Perillae 10～20 Radix Puerariaes 15～25.
2, the urticarial medicine of treatment according to claim 1 is characterized in that the ratio of weight and number of described each component is:
Rhizoma Zingiberis Recens 10～15 Cortex Mori 15～20
Folium Perillae 10～15 Radix Puerariaes 15～20.
3, the urticarial medicine of treatment according to claim 1 is characterized in that described medicine is made capsule.
4, the preparation method of the urticarial medicine of the described treatment of claim 3, be with above-mentioned various medicines according to described ratio of weight and number mix homogeneously after, decoct with water 3 times, each 0.5～1 hour, merge 3 times decocting liquid, filter, be condensed into 60 ℃ of relative densities and be 1.25～1.3 thick paste, after 50～60 ℃ of dryings, be ground into 100～120 medicated powder, in incapsulating, sterilization makes the capsule product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2008100553023A CN101301461A (en) | 2008-06-25 | 2008-06-25 | Medicament for treating urticaria |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2008100553023A CN101301461A (en) | 2008-06-25 | 2008-06-25 | Medicament for treating urticaria |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101301461A true CN101301461A (en) | 2008-11-12 |
Family
ID=40111678
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2008100553023A Pending CN101301461A (en) | 2008-06-25 | 2008-06-25 | Medicament for treating urticaria |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101301461A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102205067A (en) * | 2011-06-10 | 2011-10-05 | 李克英 | Traditional Chinese medicine composition for treating chronic urticaria |
-
2008
- 2008-06-25 CN CNA2008100553023A patent/CN101301461A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102205067A (en) * | 2011-06-10 | 2011-10-05 | 李克英 | Traditional Chinese medicine composition for treating chronic urticaria |
| CN102205067B (en) * | 2011-06-10 | 2012-09-12 | 李克英 | Traditional Chinese medicine composition for treating chronic urticaria |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104173969A (en) | Traditional Chinese medicine preparation for treating chronic gastritis caused by deficient cold of spleen and stomach and preparation method thereof | |
| CN104056018A (en) | Collateral dredging and inflammation diminishing analgesic ointment | |
| CN101496864A (en) | Chinese medicament preparation for treating renal proteinuria and diabetic renal proteinuria and preparation method thereof | |
| CN103705797A (en) | Drug for treating kidney stones | |
| CN100493585C (en) | Pure Chinese traditional medicine for treating chronic pelvic inflammatory disease and menoxenia disease | |
| CN105214010A (en) | A kind of Chinese medicine preparation for the treatment of chronic cholecystitis | |
| CN101983695A (en) | Traditional Chinese medicine composition for curing hemiplegia and preparation method thereof | |
| CN102205096B (en) | Medicament for treating adnexitis and pelvic inflammation | |
| CN101549141A (en) | Traditional Chinese medicine for treating hysteromyoma and metrocystosis and preparation process thereof | |
| CN100515455C (en) | Medicine for treating posthemiplegic paralysis and coronary heart diesease | |
| CN104225507A (en) | Chinese medicine for treating limb paralysis and pain caused by cerebral hemorrhage | |
| CN101301461A (en) | Medicament for treating urticaria | |
| CN103550548B (en) | A kind of Chinese medicine composition for the treatment of constipation | |
| CN102670893A (en) | Traditional Chinese medicine composition for treating atherosclerosis | |
| CN102526384B (en) | Medicament for treating rheumatism and preparation method thereof | |
| CN105343217A (en) | Traditional Chinese medicine formula for treating chronic gastric disease | |
| CN104971332A (en) | Traditional Chinese medicine for treating hemorrhoids | |
| CN104225376A (en) | Traditional Chinese medicinal composition for treating pernicious vomiting due to liver-stomach disharmony and application thereof | |
| CN104435641A (en) | Traditional Chinese medicine preparation for treating hyperthyroidism | |
| CN104055959A (en) | Traditional Chinese medicine lotion and nursing method for treating gastrointestinal dampness-heat type seborrhoeic dermatitis | |
| CN103566241A (en) | Traditional Chinese medicinal composition for treating diarrhea | |
| CN101229255A (en) | Chinese traditional medicine formulation for treating acute waist injury | |
| CN106075268A (en) | A kind of Chinese medicine composition treating scabies | |
| CN105126003A (en) | Traditional Chinese medicine composition for preventing and curing madness and preparation method | |
| KR20240102982A (en) | Traditional Chinese herbal medicine for the treatment of hives, eczema, allergies/kinetic reactive constitution |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20081112 |